Conflict of Interest Disclosure Index:
Conflict of Interest Disclosure Index:
A
Sanofi, Biogen, Teva, Genentech, Novartis, Bayer:
Consulting and/or speaker honoraria, and scientific advisory boards
Novartis: Research grants
Novartis: Research grants
Bayer, Biogen, Biologix, Genpharm, GSK, Lundbeck, Merck Serono, Novartis, and Sanofi:
Speakers Bureau
Bayer, Biogen, Biologix, Genpharm, GSK, Lundbeck, Merck Serono, Novartis, and Sanofi: Contracted research
Bayer, Biogen, Biologix, Genpharm, GSK, Lundbeck, Merck Serono, Novartis, and Sanofi: Speaker honoraria, scientific advisory boards, and research grants
Current Treatment Options in Neurology: Member of the editorial board
Biogen and Novartis: Research grants
Bayer, Biogen, Merck Serono, Novartis, Roche, and Sanofi: Speakers Bureau
Bayer, Biogen, Biologix, Genpharm, GSK, Lundbeck, Merck Serono, Novartis, and Sanofi: Contracted research
Bayer, Biogen, Biologix, Genpharm, GSK, Lundbeck, Merck Serono, Novartis, and Sanofi: Speaker honoraria, scientific advisory boards, and research grants
Current Treatment Options in Neurology: Member of the editorial board
Biogen and Novartis: Research grants
Bayer, Biogen, Merck Serono, Novartis, Roche, and Sanofi: Speakers Bureau
Elizabeth Andrews works for RTI Health Solutions, a business unit of RTI International, which has been compensated for this research. RTI International is an independent, nonprofit research organization that conducts work for government, public, and....:
Contracted research
... private organizations including pharmaceutical companies.: Contracted research
... private organizations including pharmaceutical companies.: Contracted research
Acorda, Bayer, Biogen, Canadian Institutes of Health Research, Eli Lilly, EMD Serono, genentech, GlaxoSmithKline, MedImmune, Merck Serono, MS Society of canada, NeuroRx Research, Novartis, Opexa Therapeutics, receptos, Roche, Sanofi, and Teva:
Compensation for serving as a speaker, consultant, and advisory board participant, and receiving research support
Acorda, Biogen Idec, F. Hoffmann-La Roche, Genentech, Genzyme, Novartis and Sanofi-Aventis: Consulting Fee and Contracted research
NeuroRx Research: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Acorda, Biogen, MedImmune, Mitsubishi Pharma, Novartis, Receptos, Roche, and Sanofi: Consulting Fee
Biogen and Novartis: Grant support
Acorda, Biogen Idec, F. Hoffmann-La Roche, Genentech, Genzyme, Novartis and Sanofi-Aventis: Consulting Fee and Contracted research
NeuroRx Research: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Acorda, Biogen, MedImmune, Mitsubishi Pharma, Novartis, Receptos, Roche, and Sanofi: Consulting Fee
Biogen and Novartis: Grant support
Ipsen:
Contracted research
B
Shareholder of F. Hoffmann-La Roche:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
F. Hoffmann-La Roche Ltd: Employee of and Salary
F. Hoffmann-La Roche: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
F. Hoffmann-La Roche Ltd: Employee of and Salary
F. Hoffmann-La Roche: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
BIOGEN:
Speakers Bureau
Grant/research support from Biogen:
Contracted research
Biogen, Sanofi, and Teva: Consulting Fee
Biogen, Sanofi, and Teva: Consulting Fee
Biogen:
Consulting Fee
Biogen, Genzyme: Consulting Fee
Biogen, Genzyme: Consulting Fee
Biogen Idec, Merck Serono, Novartis and Teva Neuroscience:
Consulting Fee
and
Contracted research
Amplimmune, Bayhill Therapeutics, Berlex/Bayer, Biogen Idec, DioGenix, Eli Lilly, Genentech, Genzyme, GlaxoSmithKline, Guthy-Jackson/GGF, Merck/EMD Serono, Medimmune, Mitsubishi Pharma, Novartis, Ono Pharma, Receptos, Roche, Sanofi, Teva Neuroscience:
Consulting Fee
and
Contracted research
Wyeth: Consulting Fee and Contracted research
Wyeth: Consulting Fee and Contracted research
Biogen, Celgene/Receptos, EMD Serono, Genzyme, Medimmune, Novartis, and Roche:
Consulting Fee
Atara Biotherapeutics, Biogen Idec, Celgene/Receptos, Genentech/Roche, GlaxoSmithKline, Medimmune, Merck/EMD Serono, Novartis, Sanofi-Genzyme: Speakers Bureau
Atara Biotherapeutics, Biogen Idec, Celgene/Receptos, Genentech/Roche, GlaxoSmithKline, Medimmune, Merck/EMD Serono, Novartis, Sanofi-Genzyme: Contracted research
Atara Biotherapeutics, Biogen Idec, Celgene/Receptos, Genentech/Roche, GlaxoSmithKline, Medimmune, Merck/EMD Serono, Novartis, Sanofi-Genzyme: Consulting Fee
Atara Biotherapeutics, Biogen Idec, Celgene/Receptos, Genentech/Roche, GlaxoSmithKline, Medimmune, Merck/EMD Serono, Novartis, Sanofi-Genzyme: Speakers Bureau
Atara Biotherapeutics, Biogen Idec, Celgene/Receptos, Genentech/Roche, GlaxoSmithKline, Medimmune, Merck/EMD Serono, Novartis, Sanofi-Genzyme: Contracted research
Atara Biotherapeutics, Biogen Idec, Celgene/Receptos, Genentech/Roche, GlaxoSmithKline, Medimmune, Merck/EMD Serono, Novartis, Sanofi-Genzyme: Consulting Fee
EMD Serono:
Consulting Fee
Teva: Consulting Fee
Teva: Consulting Fee
Sanofi-Genzyme:
Consulting Fee
,
Speakers Bureau
and
Travel to meeting
Biogen: Consulting Fee and Speakers Bureau
Roche: Consulting Fee and Travel to meeting
Merck: Consulting Fee
Biogen: Consulting Fee and Speakers Bureau
Roche: Consulting Fee and Travel to meeting
Merck: Consulting Fee
Biogen-Idec, TEVA, Merck-Serono, Novartis, Roche, Jansen Research, Genzyme-Sanofi, IXICO Ltd, GeNeuro and Apitope Ltd.:
Consulting Fee
Biogen, Novartis, and Sanofi:
Institutional support for research, speaking, and/or participation in advisory boards
Medical Safety Systems: Research consultant
Medical Safety Systems: Research consultant
Irody, Inc.:
Employed by the company who provided the technology platform for this study.
Research with NIH, NMSS, Novartis, MedImmune, Actelion, Chugai, EMD Serono, Biogenidec:
Contracted research
Biogen, Mallinckrodt, Novartis, Roche-Genentech, Sanofi, and Teva Neuroscience:
Consulting fees/fees for non-CME services from commercial interest or their agents/grant and research support
Mallinckrodt ARD Inc:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
F. Hoffmann-La Roche Ltd:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Roche: Salary
Roche: Salary
Bayer, Biogen, Genzyme, Genentech:
Consulting Fee
and
Contracted research
Novartis and Biogen: Contracted research
Novartis and Biogen: Contracted research
Biogen, EMD Serono, Novartis Pharmaceuticals, Genentech, Genzyme Corporation, Teva Pharmaceuticals:
Consultant
Biogen, Novartis Pharmaceuticals: Grant support
Biogen, Novartis Pharmaceuticals: Grant support
Employee of Sanofi:
Salary
Biogen:
Consulting Fee
and
Research Support
Genzyme: Consulting Fee , Contracted research and Research Support
Mallinkrodt: Research support
Abbvie: Consulting Fee
Genentech, Inc.: Consulting Fee
Roche: Consulting Fee
Teva: Consulting Fee
Novartis: Consulting Fee
EMD Serono: CME
Psychological Assessment Resources, Inc.: Royalty
Genzyme: Consulting Fee , Contracted research and Research Support
Mallinkrodt: Research support
Abbvie: Consulting Fee
Genentech, Inc.: Consulting Fee
Roche: Consulting Fee
Teva: Consulting Fee
Novartis: Consulting Fee
EMD Serono: CME
Psychological Assessment Resources, Inc.: Royalty
Amgen, Astra-Zeneca, Janssen, Millennium/Takeda, Novartis, Biogen, Roche, Genentech, Genzyme/Sanofi, Inhibikase, Forward Pharma, Johnson and Johnson, Pfizer, and Eisai:
Fees for non-CME services received directly from a commercial interest or its agent
and
Grants from Biogen
Acorda, Avanair, Bayer, Biogen, Novartis, Questor, Sanofi, and Teva:
Advisory Boards
Acorda, Avanair, Bayer, Biogen, Novartis, Questor, Sanofi, and Teva: Consulting Fee
Acorda, Avanir, Bayer, Biogen, Novartis, Questcor, Sanofi, and Teva: Advisory boards and consulting
Acorda, Avanair, Bayer, Biogen, Novartis, Questor, Sanofi, and Teva: Consulting Fee
Acorda, Avanir, Bayer, Biogen, Novartis, Questcor, Sanofi, and Teva: Advisory boards and consulting
Bayer AG:
Consulting Fee
Biogen: Consulting Fee and Speakers Bureau
Mallinckrodt Pharmaceuticals: Consulting Fee
Novartis AG: Consulting Fee and Speakers Bureau
Sanofi Genzyme: Consulting Fee and Speakers Bureau
Teva Pharmaceutical Industries Ltd: Consulting Fee and Speakers Bureau
Acorda Therapeutics: Consulting Fee and Speakers Bureau
Avanir Pharmaceuticals, Inc: Consulting Fee and Speakers Bureau
Biogen: Consulting Fee and Speakers Bureau
Mallinckrodt Pharmaceuticals: Consulting Fee
Novartis AG: Consulting Fee and Speakers Bureau
Sanofi Genzyme: Consulting Fee and Speakers Bureau
Teva Pharmaceutical Industries Ltd: Consulting Fee and Speakers Bureau
Acorda Therapeutics: Consulting Fee and Speakers Bureau
Avanir Pharmaceuticals, Inc: Consulting Fee and Speakers Bureau
Atlas5D:
Contracted research
Biogen: Contracted research and Royalty
Ipsen: Consulting Fee
Biogen: Contracted research and Royalty
Ipsen: Consulting Fee
Biogen, Mallinckrodt, Medtronic, Novartis, Sanofi, and Teva:
Consulting Fee
Biogen, Mallinckrodt, Medtronic, Novartis, Sanofi, and Teva: Fees for non-CME services received directly from a commercial interest or its agent
Biogen, Mallinckrodt, Medtronic, Novartis, Sanofi, and Teva: Consulting Fee and Fees for non-CME services received directly from a commercial interest or its agent
Biogen, Novartis, Sanofi Genzyme, Genentech, TEVA, and Medtronic: Consulting Fee
Biogen, TEVA, Novartis, Genentech and Roche: Contracted research
Biogen, Mallinckrodt, Medtronic, Novartis, Sanofi, and Teva: Fees for non-CME services received directly from a commercial interest or its agent
Biogen, Mallinckrodt, Medtronic, Novartis, Sanofi, and Teva: Consulting Fee and Fees for non-CME services received directly from a commercial interest or its agent
Biogen, Novartis, Sanofi Genzyme, Genentech, TEVA, and Medtronic: Consulting Fee
Biogen, TEVA, Novartis, Genentech and Roche: Contracted research
Sanofi-Genzyme, Roche-Genentech and Novartis:
Consulting Fee
Acorda Therapeutics:
Consulting Fee
,
Contracted research
and
Speakers Bureau
Biogen IDEC: Consulting Fee , Contracted research and Speakers Bureau
Alexion: Contracted research
Alkermes: Contracted research
Allergan: Contracted research
Amgen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Genentech: Consulting Fee , Contracted research and Speakers Bureau
Genzyme: Consulting Fee and Contracted research
Novartis Pharmaceuticals Corporation: Consulting Fee , Contracted research and Speakers Bureau
GlaxoSmithKline: Contracted research
Roche: Contracted research
Sanofi-Aventis: Contracted research
Teva Neuroscience: Consulting Fee and Speakers Bureau
Biogen IDEC: Consulting Fee , Contracted research and Speakers Bureau
Alexion: Contracted research
Alkermes: Contracted research
Allergan: Contracted research
Amgen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Genentech: Consulting Fee , Contracted research and Speakers Bureau
Genzyme: Consulting Fee and Contracted research
Novartis Pharmaceuticals Corporation: Consulting Fee , Contracted research and Speakers Bureau
GlaxoSmithKline: Contracted research
Roche: Contracted research
Sanofi-Aventis: Contracted research
Teva Neuroscience: Consulting Fee and Speakers Bureau
Bayer-Schering, Biogen, Merck Serono, Novartis, and Sanofi:
Honoraria for participation in advisory boards
Bayer-Schering, Biogen, Merck Serono, Novartis, and Sanofi: Conference travel sponsorship
Biogen and Genzyme: Speaker honoraria
Biogen: Unencumbered research grant
Bayer-Schering, Biogen, Merck Serono, Novartis, and Sanofi: Conference travel sponsorship
Biogen and Genzyme: Speaker honoraria
Biogen: Unencumbered research grant
Novartis, Biogen:
Consulting Fee
Bayer, Merck, Genzyme, Biogen, Novartis, Roche, Actelion, Medday, Teva: Contracted research
Bayer, Merck, Genzyme, Biogen, Novartis, Roche, Actelion, Medday, Teva: Contracted research
Biogen, Novartis, Sanofi:
Research support
Novartis, Sanofi, Biogen, Acorda, Avanir, Teva, and UCB: Consulting and/or speaker honoraria
Novartis, Sanofi, Biogen, Acorda, Avanir, Teva, and UCB: Consulting and/or speaker honoraria
The author’s employer (RTI Health Solutions) performs work for multiple pharma and biotech companies, including the study sponsor, on a contract basis; however the author does not receive any of those funds directly nor is his/her salary contingent upon t:
Contracted research
Ipsen:
Consulting Fee
Biogen: Consulting Fee
Teva: Consulting Fee
Sanofi-Genzyme: Consulting Fee
Merck: Contracted research
Astellas: Contracted research
Biogen: Contracted research
Biogen: Consulting Fee
Teva: Consulting Fee
Sanofi-Genzyme: Consulting Fee
Merck: Contracted research
Astellas: Contracted research
Biogen: Contracted research
Biogen Idec:
Consulting Fee
and
Contracted research
Sanofi-Genzyme: Consulting Fee
Teva Neuroscience: Consulting Fee
Ibsen pharaceutical: Consulting Fee
Astellas: Contracted research
Merck: Contracted research
Sanofi-Genzyme: Consulting Fee
Teva Neuroscience: Consulting Fee
Ibsen pharaceutical: Consulting Fee
Astellas: Contracted research
Merck: Contracted research
Bayer Vital, Biogen, Genzyme, Merck Serono, Novartis, Sanofi-Aventis and Teva Pharma:
Consulting Fee
and
Contracted research
F. Hoffmann-La Roche Ltd:
Employee of
Biogen, Genentech , Genzyme and Teva:
Speaker fees
Novartis:
Jeri Burtchell, as an employee of HealthiVibe, LLC, has worked on projects with many pharmaceutical companies.
CureClick and MS SoftServe, Inc.: Patient advisory boards
CureClick and MS SoftServe, Inc.: Patient advisory boards
C
PAC has received consulting fees from Disarm Therapeutics, and is PI on research grants to JHU from Annexon, MedImmune, Sanofi, Biogen and Novartis. Peter:
Consulting Fee
Dr. Calabresi has received grant support paid to his institution from Annexon, Biogen, MedImmune, Novartis, Sanofi Genzyme, and Teva, and consulting fees from Biogen and DiSARM Therapeutics: Consulting Fee and Contracted research
Dr. Calabresi has received grant support paid to his institution from Annexon, Biogen, MedImmune, Novartis, Sanofi Genzyme, and Teva, and consulting fees from Biogen and DiSARM Therapeutics: Consulting Fee and Contracted research
Celgene:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Employee of and own stock and/or stock options in Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Sanofi:
Employee
Sanofi: Holder of stock
Sanofi: Holder of stock
Roche:
Consulting Fee
EMD Serono: Consulting Fee
Sanofi: Consulting Fee
Biogen: Consulting Fee
Novartis: Consulting Fee
Teva: Consulting Fee
EMD Serono: Consulting Fee
Sanofi: Consulting Fee
Biogen: Consulting Fee
Novartis: Consulting Fee
Teva: Consulting Fee
Research support unrelated to this study (AAAAI/VAMPS, AbbVie Laboratories, Amgen Inc., Bristol-Myers/Squibb, Celgene, Genzyme Sanofi-Aventis, GlaxoSmithKline, Hoffman-La Roche-Genentech, Janssen Pharmaceuticals, Pfizer, Inc., Seqirus, Takeda, UCB USA):
Contracted research
Birth Defects Research Part A: Clinical and Molecular Teratology: Compensation for serving as Editor, Associate Editor, or member of an editorial advisory board
Birth Defects Research Part A: Clinical and Molecular Teratology: Compensation for serving as Editor, Associate Editor, or member of an editorial advisory board
Employee of and own stock and/or stock options in Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Foundation of the Consortium of Multiple Sclerosis Centers’ MS Workforce of the Future program as well as the MS Connect Program:
Grant
Employee of Sanofi:
Salary
TEVA, Novartis, Genzyme and Sanofy, Biogen, Acorda, Mallinckrodt:
Consulting Fee
and
Contracted research
Sanofi:
Employee
Biogen, F. Hoffmann-La Roche, Merck Serono and Novartis:
Consulting Fee
and
Contracted research
Bayer, Novartis, and Roche-Genentech:
Consulting Fee
EMD Serono, Octave, and Verily Life Sciences: Contracted research
Novartis, Sanofi-Genzyme, and Roche-Genentech: Serves on clinical trials advisory board for
EMD Serono, Octave, and Verily Life Sciences: Contracted research
Novartis, Sanofi-Genzyme, and Roche-Genentech: Serves on clinical trials advisory board for
F. Hoffmann-La Roche Ltd:
Employee of
Sanofi:
Employee
Teva:
Speakers Bureau
Employee of Genentech Inc:
Salary
Biogen:
Consulting Fee
,
Contracted research
and
Speakers Bureau
Sanofi-Genzyme: Consulting Fee , Contracted research and Speakers Bureau
Novartis: Consulting Fee , Contracted research and Speakers Bureau
Roche-Genentech: Consulting Fee , Contracted research and Speakers Bureau
Mallinkrodt: Contracted research
Acorda: Speakers Bureau
Sanofi-Genzyme: Consulting Fee , Contracted research and Speakers Bureau
Novartis: Consulting Fee , Contracted research and Speakers Bureau
Roche-Genentech: Consulting Fee , Contracted research and Speakers Bureau
Mallinkrodt: Contracted research
Acorda: Speakers Bureau
Genentech, Merck, Novartis, and Receptos:
Consulting Fee
and
Contracted research
Adamas and Celgene: Consulting Fee
Multiple Sclerosis Journal – Experimental, Translational and Clinical: Co-editor
Adamas and Celgene: Consulting Fee
Multiple Sclerosis Journal – Experimental, Translational and Clinical: Co-editor
Actelion, Bayer, Merck Serono, Novartis, Sanofi, and Teva:
Consulting Fee
Bayer, Biogen Dompe, Merck Serono, Novartis, Sanofi, Serono Symposia International Foundation, and Teva: Lecture Fees
Bayer, Biogen Dompe, Merck Serono, Novartis, Sanofi, Serono Symposia International Foundation, and Teva: Lecture Fees
Novartis, Teva Pharmaceutical Ind. Ltd., Sanofi-Aventis, Merck, Biogen Dompè, Bayer Schering, and Serono Symposia International Foundation:
Lecture fees
Novartis, Teva Pharmaceutical Ind. Ltd., Sanofi-Aventis, Receptos, Biogen Idec, Genentech-Roche, Merck, Biogen Dompè, and Bayer Schering: Trial grant support
Novartis, Teva Pharmaceutical Industries Ltd., Sanofi-Aventis, Merck, Receptos, Biogen Idec, Genentech-Roche, and Bayer Schering: Consulting Fee
Almirall, Biogen, Celgene/Receptos, EXCEMED, Forward Pharm, Genzyme, Merck, Novartis, Roche, Sanofi, and Teva: Consulting Fee and Speaking activities
Almirall, Biogen, Celgene, Excemed, Forward Pharma, Genzyme, Merck, Novartis, Receptos, Roche, Sanofi, Teva: Consulting Fee
Almirall, Bayer, Biogen, Excemed, Genzyme, Merck Serono, Novartis, Receptos, Sanofi, SSIF, Teva: Contracted research
Almirall, Biogen, Celgene, Excemed, Forward Pharma, Genzyme, Merck, Novartis, Receptos, Roche, Sanofi, Teva: Speakers Bureau
Novartis, Teva Pharmaceutical Ind. Ltd., Sanofi-Aventis, Receptos, Biogen Idec, Genentech-Roche, Merck, Biogen Dompè, and Bayer Schering: Trial grant support
Novartis, Teva Pharmaceutical Industries Ltd., Sanofi-Aventis, Merck, Receptos, Biogen Idec, Genentech-Roche, and Bayer Schering: Consulting Fee
Almirall, Biogen, Celgene/Receptos, EXCEMED, Forward Pharm, Genzyme, Merck, Novartis, Roche, Sanofi, and Teva: Consulting Fee and Speaking activities
Almirall, Biogen, Celgene, Excemed, Forward Pharma, Genzyme, Merck, Novartis, Receptos, Roche, Sanofi, Teva: Consulting Fee
Almirall, Bayer, Biogen, Excemed, Genzyme, Merck Serono, Novartis, Receptos, Sanofi, SSIF, Teva: Contracted research
Almirall, Biogen, Celgene, Excemed, Forward Pharma, Genzyme, Merck, Novartis, Receptos, Roche, Sanofi, Teva: Speakers Bureau
biogen, celgene, genentech, genzyme, novartis, teva,:
Consulting Fee
,
Contracted research
and
Speakers Bureau
Bayer HealthCare, Merck, Actinobac Biomed, Teva Pharmaceuticals, and Biogen Idec:
Advisory boards
Merck, Bayer HealthCare, Sanofi-Aventis, Neurology Reviews, Biogen Idec, Teva Pharmaceuticals, and Actinobac Biomed Inc: Consulting Fee and Honoraria for lectures
Bayer HealthCare: Grant support
Merck, Bayer HealthCare, Sanofi-Aventis, Neurology Reviews, Biogen Idec, Teva Pharmaceuticals, and Actinobac Biomed Inc: Consulting Fee and Honoraria for lectures
Bayer HealthCare: Grant support
Accordant:
Consulting Fee
Acorda: Consulting Fee
Bayer: Consulting Fee
Biogen: Consulting Fee
Celgene: Consulting Fee
EMD Serono: Consulting Fee
Genentech/Roche: Consulting Fee and Contracted research
Novartis: Consulting Fee and Contracted research
Sanofi Genzyme: Consulting Fee
Teva: Consulting Fee
Actelion: Contracted research
Alkermes: Contracted research
MedDay: Contracted research
National Institute of Neurological Disorders and Stroke (NINDS): Contracted research
Consulting fees (AbbVie, Accordant, Acorda, Bayer, Biogen Idec, Celgene, Genentech/Roche, Genzyme/Sanofi, Novartis, Serono, Teva): Consulting Fee
Research support (Actelion, Alkermes, Genentech/Roche, MedDay, NINDS, Novartis, Opexa).: Contracted research
Acorda: Consulting Fee
Bayer: Consulting Fee
Biogen: Consulting Fee
Celgene: Consulting Fee
EMD Serono: Consulting Fee
Genentech/Roche: Consulting Fee and Contracted research
Novartis: Consulting Fee and Contracted research
Sanofi Genzyme: Consulting Fee
Teva: Consulting Fee
Actelion: Contracted research
Alkermes: Contracted research
MedDay: Contracted research
National Institute of Neurological Disorders and Stroke (NINDS): Contracted research
Consulting fees (AbbVie, Accordant, Acorda, Bayer, Biogen Idec, Celgene, Genentech/Roche, Genzyme/Sanofi, Novartis, Serono, Teva): Consulting Fee
Research support (Actelion, Alkermes, Genentech/Roche, MedDay, NINDS, Novartis, Opexa).: Contracted research
Genzyme:
Speakers Bureau
Teva: Speakers Bureau
Biogen: Speakers Bureau
Novartis: advisory
Teva: advisory
Biogen: advisory
Teva: Speakers Bureau
Biogen: Speakers Bureau
Novartis: advisory
Teva: advisory
Biogen: advisory
AbbVie, Biogen, EMD Serono, GeNeuro, Novartis and Sanofi Genzyme:
Consulting Fee
MedDay: research support
Abbvie, Biogen, EMD Serono, Genzyme, Novartis, and Shire: Consulting Fee
Biogen: Consulting Fee
EMD Serono: Consulting Fee
Teva: Consulting Fee
MedDay: research support
Abbvie, Biogen, EMD Serono, Genzyme, Novartis, and Shire: Consulting Fee
Biogen: Consulting Fee
EMD Serono: Consulting Fee
Teva: Consulting Fee
Genentech/Roche:
Consulting Fee
and
Development of Educational Materials; Honoraria
AbbVie: Honoraria
Bayer: Honoraria
EMD Serono: Honoraria
Genzyme: Honoraria
Novartis: Honoraria
Teva: Honoraria
AbbVie: Honoraria
Bayer: Honoraria
EMD Serono: Honoraria
Genzyme: Honoraria
Novartis: Honoraria
Teva: Honoraria
AMO Pharmaceuticals, Apotek, BioLineRx, Horizon Pharmaceuticals, Modigenetech/Prolor, Merck, Merck/Pfizer, Opko Biologics, Neurim, Sanofi, Reata Pharmaceuticals, Receptos/Celgene, Teva, NHLBI [Protocol Review Committee], NICHD [OPRU oversight committee]:
Data and safety monitoring boards
Atara Biotherapeutics, Argenix, Genzyme, Genentech, GW Pharma, Klein-Buendel Incorporated, MedImmune, Medday, Novartis, Opexa Therapeutics, Roche, Savara Inc., Somahlution, Teva, Transparency Life Sciences, TG Therapeutics: Consulting or advisory boards
Atara Biotherapeutics, Argenix, Genzyme, Genentech, GW Pharma, Klein-Buendel Incorporated, MedImmune, Medday, Novartis, Opexa Therapeutics, Roche, Savara Inc., Somahlution, Teva, Transparency Life Sciences, TG Therapeutics: Consulting or advisory boards
Medday:
Consulting or Advisory Boards
Klein-Buendel Incorporated: Consulting or Advisory Boards
Innate Therapeutics: Consulting or Advisory Boards
Genentech: Consulting or Advisory Boards
Genzyme: Consulting or Advisory Boards
Consortium of MS Centers: Consulting or Advisory Boards
Bioeq GmBH: Consulting or Advisory Boards
Argenix: Consulting or Advisory Boards
Atara Biotherapeutics: Consulting or Advisory Boards
NICHD: OPRU oversight committee
NHLBI: Protocol Review Committee
Teva Pharmaceuticals: Data and Safety Monitoring Boards
Receptos/Celgene: Data and Safety Monitoring Boards
Reata Pharmaceuticals: Data and Safety Monitoring Boards
Sanofi-Aventis: Data and Safety Monitoring Boards
Neurim: Data and Safety Monitoring Boards
Opko Biologics: Data and Safety Monitoring Boards
Merck/Pfizer: Data and Safety Monitoring Boards
Merck: Data and Safety Monitoring Boards
Modigenetech/Prolor: Data and Safety Monitoring Boards
Horizon Pharmaceuticals: Data and Safety Monitoring Boards
Apotek: Data and Safety Monitoring Boards
AMO Pharmaceuticals: Data and Safety Monitoring Boards
Novartis: Consulting or Advisory Boards
Opera Therapeutics: Consulting or Advisory Boards
Roche: Consulting or Advisory Boards
Savara Inc.: Consulting or Advisory Boards
Somahlution: Consulting or Advisory Boards
Teva pharmaceuticals: Consulting or Advisory Boards
Transparency Life Sciences: Consulting or Advisory Boards
TG Therapeutics: Consulting or Advisory Boards
Klein-Buendel Incorporated: Consulting or Advisory Boards
Innate Therapeutics: Consulting or Advisory Boards
Genentech: Consulting or Advisory Boards
Genzyme: Consulting or Advisory Boards
Consortium of MS Centers: Consulting or Advisory Boards
Bioeq GmBH: Consulting or Advisory Boards
Argenix: Consulting or Advisory Boards
Atara Biotherapeutics: Consulting or Advisory Boards
NICHD: OPRU oversight committee
NHLBI: Protocol Review Committee
Teva Pharmaceuticals: Data and Safety Monitoring Boards
Receptos/Celgene: Data and Safety Monitoring Boards
Reata Pharmaceuticals: Data and Safety Monitoring Boards
Sanofi-Aventis: Data and Safety Monitoring Boards
Neurim: Data and Safety Monitoring Boards
Opko Biologics: Data and Safety Monitoring Boards
Merck/Pfizer: Data and Safety Monitoring Boards
Merck: Data and Safety Monitoring Boards
Modigenetech/Prolor: Data and Safety Monitoring Boards
Horizon Pharmaceuticals: Data and Safety Monitoring Boards
Apotek: Data and Safety Monitoring Boards
AMO Pharmaceuticals: Data and Safety Monitoring Boards
Novartis: Consulting or Advisory Boards
Opera Therapeutics: Consulting or Advisory Boards
Roche: Consulting or Advisory Boards
Savara Inc.: Consulting or Advisory Boards
Somahlution: Consulting or Advisory Boards
Teva pharmaceuticals: Consulting or Advisory Boards
Transparency Life Sciences: Consulting or Advisory Boards
TG Therapeutics: Consulting or Advisory Boards
D
Teva Pharma, Biogen, Novartis, Roche, Sanofi-Genzyme, Bayer-Schering, Merck-Serono and Allergan.:
consultancy fees, travel and research grants
Sanofi:
Employee
EMD Serono, Inc.:
Salary
Roche:
Consulting Fee
Roche:
Consulting Fee
Merck Serono:
Consulting Fee
Sanofi: Consulting Fee
Teva: Consulting Fee
Biogen: Consulting Fee
Novartis: Consulting Fee
Sanofi: Consulting Fee
Teva: Consulting Fee
Biogen: Consulting Fee
Novartis: Consulting Fee
Teva:
Consulting Fee
Biogen: Consulting Fee
Biogen: Consulting Fee
F. Hoffmann-La Roche Ltd:
Employee of
and
Salary
Celgene:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Bayer, Merck Serono, Novartis, Sanofi, and Teva:
Institutional honoraria for advisory board participation and travel grants
Sanofi:
Participation in advisory boards
Acorda Therapeutics:
Speakers Bureau
Neurotrax Corporation:
Salary
RTI Health Solutions:
Salary
RTI-HS: RTI-HS performs work for the sponsor and other pharma companies on a contract basis, but the I do not receive any of those funds nor is my salary contingent upon the results of the work for those pharma entities.
RTI-HS: RTI-HS performs work for the sponsor and other pharma companies on a contract basis, but the I do not receive any of those funds nor is my salary contingent upon the results of the work for those pharma entities.
MedLogix Communications, LLC/Mallinckrodt ARD Inc:
Editorial support was provided by MedLogix Communications, LLC, Itasca, Illinois, under the direction of the authors and was funded by Mallinckrodt ARD Inc.
Mallinckrodt ARD Inc.: Salary
Mallinckrodt ARD Inc.: Salary
E
Oxford PharmaGenesis:
Employee
Biogen, Sanofi Genzyme, Actelion, Eisai, Eli Lily, Forum Pharmaceuticals, Genentech, Hoffman-LaRoche, Merz Pharmaceuticals, Novartis, Pfizer, Vaccinex:
Consulting Fee
,
Contracted research
and
Speakers Bureau
Biogen:
Salary
Health Services Consulting Corporation, which received funding from EMD Serono, Inc. to run the analysis:
Employment
TG Therapeutics:
employee
F. Hoffmann-La Roche:
Employee of
and
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
F. Hoffmann-La Roche: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Roche Products Ltd: Employee of
Roche Products Ltd: Employee of and Salary
F. Hoffmann-La Roche Ltd: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
F. Hoffmann-La Roche: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Roche Products Ltd: Employee of
Roche Products Ltd: Employee of and Salary
F. Hoffmann-La Roche Ltd: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
F
Bayer US LLC.:
Salary
Merck Serono:
scientific advisory board
Avanir Pharmaceuticals: scientific advisory board
Merck Serono: Speakers Bureau
Teva Pharmaceuticals Industries LTd.: Speakers Bureau
Bayer Schering Pharma: Speakers Bureau
Biogen Idec.: Speakers Bureau
The Clinical Neuropsychiatry of Multiple Sclerosis: Royalty
Avanir Pharmaceuticals: scientific advisory board
Merck Serono: Speakers Bureau
Teva Pharmaceuticals Industries LTd.: Speakers Bureau
Bayer Schering Pharma: Speakers Bureau
Biogen Idec.: Speakers Bureau
The Clinical Neuropsychiatry of Multiple Sclerosis: Royalty
Hospital Foundation FIMABIS:
Contracted research
Allergan, Almirall, Bayer-Schering, Biogen, Merck Serono, Novartis, Sanofi, and Teva: Speaking/Consulting
Revista Espanola de Esclerosis Multiple: Compensation for serving as journal editor, associate editor, or member of editorial advisory board
Allergan, Almirall, Bayer-Schering, Biogen, Merck Serono, Novartis, Sanofi, and Teva: Speaking/Consulting
Revista Espanola de Esclerosis Multiple: Compensation for serving as journal editor, associate editor, or member of editorial advisory board
Genentech Inc.:
Salary
Employee of and holds stock and/or stock options in Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Sanofi Genzyme:
Speakers Bureau
Personal compensation and compensation for consulting activities from Biogen, Genentech, Genzyme, Teva:
Consulting Fee
AbbVie, Acorda Therapeutics, Allergan, Bayer, Biogen, Chugai, EMD Serono, Genentech, Novartis, Roche, Sanofi Genzyme, Teva, TG Therapeutics:
Consulting Fee
and
Contracted research
Biogen-Idec and Genetech:
Consulting Fee
Actelion, Biogen, Genentech, Novartis, Teva:
Consulting Fee
Actelion, Biogen, Novartis: Advisory committees
Biogen, Novartis: Clinical trial contract and research grant funding
Actelion, Biogen, Genentech, Novartis, and Teva: Consulting Fee
Clinical trial contract and research grant funding from Biogen and Novartis: Contracted research
Advisory board committees for Actelion, Biogen, and Novartis: Speakers Bureau
Grant/research support from Novartis: Contracted research
Advisory board from Biogen and Novartis: Speakers Bureau
Actelion, Biogen, Genentech, Mallinckrodt, MedDay, Novartis, Teva, and XenoPort: Consulting Fee
Actelion, Biogen, Novartis: Advisory committees
Biogen, Novartis: Clinical trial contract and research grant funding
Actelion, Biogen, Genentech, Novartis, and Teva: Consulting Fee
Clinical trial contract and research grant funding from Biogen and Novartis: Contracted research
Advisory board committees for Actelion, Biogen, and Novartis: Speakers Bureau
Grant/research support from Novartis: Contracted research
Advisory board from Biogen and Novartis: Speakers Bureau
Actelion, Biogen, Genentech, Mallinckrodt, MedDay, Novartis, Teva, and XenoPort: Consulting Fee
Actelion, Bayer, Biogen, Hoffman-LaRoche, Merck Serono, Novartis, Opexa, and Sanofi:
Serving on advisory boards, board of directors, or other similar group
Actelion, Bayer, Biogen, Canada Innovation, Chugai, EMD Canada, Hoffman-La Roche, Merck-Serono, Novartis, Sanofi, and Teva: Honoraria or consulting fees
Sanofi: Speakers Bureau
Bayer HealthCare, Biogen Idec, EMD Canada, Novartis, Sanofi, Teva Canada Innovation: Consulting Fee
Bayer HealthCare, Genzyme: Contracted research
Bayer HealthCare, Biogen Idec, Chugai, Merck Serono, Novartis, Opexa Therapeutics, Sanofi, Teva Canada Innovation: Member of company advisory boards/board of directors/other similar group
Actelion, Bayer, Biogen, Canada Innovation, Chugai, EMD Canada, Hoffman-La Roche, Merck-Serono, Novartis, Sanofi, and Teva: Honoraria or consulting fees
Sanofi: Speakers Bureau
Bayer HealthCare, Biogen Idec, EMD Canada, Novartis, Sanofi, Teva Canada Innovation: Consulting Fee
Bayer HealthCare, Genzyme: Contracted research
Bayer HealthCare, Biogen Idec, Chugai, Merck Serono, Novartis, Opexa Therapeutics, Sanofi, Teva Canada Innovation: Member of company advisory boards/board of directors/other similar group
Elliot Frohman has received speaker and consultant fees from Novartis, Genzyme, Acorda.:
Consulting Fee
Teresa Frohman has received speaker fees from Acorda:
Fees for non-CME services received directly from a commercial interest or its agent
G
Bayer Vital, Biogen, Novartis and Teva:
Consulting Fee
and
Contracted research
Biogen:
Consulting Fee
Shareholder of F. Hoffmann-La Roche:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
F. Hoffmann-La Roche Ltd: Employee of and Salary
F. Hoffmann-La Roche Ltd: Employee of and Salary
MedDay:
research support
Almirall, Biogen, Genzyme, Merck Serono, Novartis, Sanofi-Aventis and Teva:
Consulting Fee
and
Contracted research
Biogen Idec, Merck, Novartis, and Ironwood:
Research support
Abbvie, Atara Bio, Almirall, Bayer Schering Pharma, Biogen Idec FivePrime, GlaxoSmithKline, GW Pharma, Merck, Pfizer Inc, Protein Discovery Laboratories, Teva Pharmaceutical Industries Ltd, Sanofi-Genzyme, UCB, Vertex Pharmaceuticals, Ironwood, and Novart: Consulting Fee and Speaker honoraria
AbbVie, Atara Biotherapeutics, Almirall, Biogen, Celgene, GlaxoSmithKline, MedDay Pharmaceuticals, Merck & Co (US), Merck Group (Europe), Novartis, Oxford PharmaGenesis, Roche, Sanofi Genzyme, Synthon, Takeda, Teva Pharmaceutical Industries Ltd., UCB (MS): Consulting Fee
Biogen, Sanofi Genzyme, Takeda (multiple sclerosis): Grant/research support
Abbvie, Atara Bio, Almirall, Bayer Schering Pharma, Biogen Idec FivePrime, GlaxoSmithKline, GW Pharma, Merck, Pfizer Inc, Protein Discovery Laboratories, Teva Pharmaceutical Industries Ltd, Sanofi-Genzyme, UCB, Vertex Pharmaceuticals, Ironwood, and Novart: Consulting Fee and Speaker honoraria
AbbVie, Atara Biotherapeutics, Almirall, Biogen, Celgene, GlaxoSmithKline, MedDay Pharmaceuticals, Merck & Co (US), Merck Group (Europe), Novartis, Oxford PharmaGenesis, Roche, Sanofi Genzyme, Synthon, Takeda, Teva Pharmaceutical Industries Ltd., UCB (MS): Consulting Fee
Biogen, Sanofi Genzyme, Takeda (multiple sclerosis): Grant/research support
AbbVie, Almirall, Atara Biotherapeutics, Biogen, Bayer HealthCare, Canbex, Ironwood, Merck, Merck Serono, Novartis, Roche, Sanofi Genzyme, Synthon, Teva and Vertex.:
Consulting Fee
and
Contracted research
EMD Serono, ADAMAS, Endece, Teva, Genzyme, Novartis:
Consulting Fee
Verily Life Sciences:
Salary
EMD Serono:
Speaking Fee
Teva: Speaking Fee
Teva: Speaking Fee
AbbVie, Acorda Therapeutics, Biogen Idec, EMD Serono, Genentech/Roche, Sanofi Genzyme, Novarties, Turdue, Teva Neurosciences:
Consulting Fee
Biogen, Teva, Genzyme:
Consulting Fee
acorda, genzyme, novartis, teva:
Consulting Fee
,
Contracted research
and
Speakers Bureau
Biogen:
grant support
Genentech: Grant support
Genentech: Grant support
Acorda, Chugai, EMD Serono, Genentech, Medimmune, National Multiple Sclerosis Society, National Institutes of Health, Novartis, Patient-Centered Outcomes Research Institute and The Myositis Association:
Consulting Fee
and
Contracted research
Biogen:
Contracted research
and
Speaker Fee
EMD Serono: Contracted research and Speaker Fee
Novartis: Contracted research and Speakef Fee
Sanofi-Genzyme: Contracted research and Speaker Fee
Teva: Contracted research and Speaker Fee
Acorda: Speaker Fee
Amgen: Speaker Fee
EMD Serono: Contracted research and Speaker Fee
Novartis: Contracted research and Speakef Fee
Sanofi-Genzyme: Contracted research and Speaker Fee
Teva: Contracted research and Speaker Fee
Acorda: Speaker Fee
Amgen: Speaker Fee
Roche, Sanofi-Genzyme, Merck, Novartis, Biogen:
Consulting Fee
H
Roche, Biogen, Merck, Oxford PharmaGenesis (multiple sclerosis):
Consulting Fee
Roche, Biogen, Merck (multiple sclerosis): Speakers Bureau
Biogen, Merck (multiple sclerosis): Travel assistance
Roche, Biogen, Merck (multiple sclerosis): Speakers Bureau
Biogen, Merck (multiple sclerosis): Travel assistance
CMSC grant:
Contracted research
MyHealios:
Salary
Genentech: Contracted research
Genentech: Contracted research
TEVA:
Speakers Bureau
EMD Serono, Hoffmann-La Roche Limited, Sanofi Genzyme, Pendopharm, Biogen Canada, and Novartis Pharmaceuticals:
Consulting Fee
Bayer, Biogen, CSL Behring, Grifols, Merck Serono, Novartis, Roche, and Sanofi:
Consulting and/or speaking fees
Bayer, Biogen, Geneuro, Genzyme, Merck, Medimmune, Novartis, Octapharma, Opexa, Roche, Sanofi, and Teva: Consulting Fee , Speakers Bureau and Steering Committee
Bayer, Biogen, Geneuro, Genzyme, Merck, Medimmune, Novartis, Octapharma, Opexa, Roche, Sanofi, and Teva: Consulting Fee , Speakers Bureau and Steering Committee
Sanofi:
Employee
Employee of Sanofi: Salary
Employee of Sanofi: Salary
Annexon:
Scientific Advisory Board
Symbiotix: Scientific Advisory Board
Bionure: Scientific Advisory Board
Molecular Stethoscope: Scientific Advisory Board
Neurona Therapeutics: Board of Trustees
F. Hoffman-La Roche Ltd: travel reimbursement and writing assistance
Options granted for the SAB and BOT activities: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Symbiotix, Annexon, Bionure, and Molecular Stethoscope: Scientific advisory board
F. Hoffman-La Roche Ltd. for CD20-related meetings and presentations.: Travel reimbursement and writing assistance
Symbiotix: Scientific Advisory Board
Bionure: Scientific Advisory Board
Molecular Stethoscope: Scientific Advisory Board
Neurona Therapeutics: Board of Trustees
F. Hoffman-La Roche Ltd: travel reimbursement and writing assistance
Options granted for the SAB and BOT activities: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Symbiotix, Annexon, Bionure, and Molecular Stethoscope: Scientific advisory board
F. Hoffman-La Roche Ltd. for CD20-related meetings and presentations.: Travel reimbursement and writing assistance
Dr. Havla has received consultancy fees from Novartis, Genzyme, Santhera and Merck. He has received reimbursements of congress attendance and travel costs from Novartis, Merck, and Bayer.:
Consulting Fee
Actelion, Biogen, Celgene, Merck, Novartis, Roche, Sanofi, and Teva:
Consulting Fee
and
Speakers Bureau
Czech Ministry of Education, project PROGRES Q27/LF1: Financial support
Czech Ministry of Education, project PROGRES Q27/LF1: Financial support
EMD Serono, Inc., Rockland, MA, USA (a business of Merck KGaA, Darmstadt, Germany):
Employment
Consortium of Multiple Sclerosis Centers:
Contracted research
Teva, Biogen Idec unbranded only:
Speakers Bureau
Biogen Idec:
Consulting Fee
Merck Serono, Novartis, Genzyme, Verily Life Sciences: Contracted research
Merck Serono, Novartis, Genzyme, Verily Life Sciences: Contracted research
Elsevier Publishing:
Royalty
Teva: Speakers Bureau
Ipsen: Speakers Bureau
Teva: Speakers Bureau
Ipsen: Speakers Bureau
Roche, Novartis, Teva, Bayer, Novartis, Merck, Genzyme, Biogen:
Speakers Bureau
Teva, Novartis, Biogen, Genzyme: Contracted research
Roche, Novartis, Teva, Bayer, Novartis, Merck, Genzyme: Consulting Fee
Teva, Novartis, Biogen, Genzyme: Contracted research
Roche, Novartis, Teva, Bayer, Novartis, Merck, Genzyme: Consulting Fee
Bernhard Hemmer has served on scientific advisory boards for F. Hoffmann-La Roche Ltd, Novartis, Bayer AG, and Genentech; he has served as DMSC member for AllergyCare and TG Therapeutics; he or his institution have received speaker honoraria from Biogen I:
Receipt of Intellectual Property Rights / Patent Holder
Biogen, EMD Serono, Teva, Genentech, Novartis:
Consulting Fee
and
Contracted research
Health Union:
Contracted research
Pfizer, GSK, Lilly:
Contracted research
Boehringer-Ingelheim, UCB: Consulting Fee
Boehringer-Ingelheim, UCB: Consulting Fee
Merck KGaA:
Salary
JAK Tool:
Consulting Fee
Moximed: Consulting Fee
Moximed: Contracted research
Moximed: Consulting Fee
Moximed: Contracted research
Employee of and own stock and/or stock options in Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Acorda, Asubio, Bayer Schering, Biogen Idec, F. Hoffmann-La Roche, Genzyme, Merck Serono, Novartis, Oxford PharmaGenesis, Teva:
Consulting Fee
and
Honoraria, meeting attendance support or research support
Employee of Biogen:
Salary
EMD Serono, Inc.:
Funding support
Biogen, Genzyme Sanofi, Teva Neuroscience, and Novartis: Advisory board
Genzyme Sanofi: Contracted research and Genzyme Sanofi
Biogen, Genzyme Sanofi, Teva Neuroscience, and Novartis: Advisory board
Genzyme Sanofi: Contracted research and Genzyme Sanofi
F. Hoffman-La Roche AG Basel:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
F. Hoffman-La Roche AG Basel: Salary
F. Hoffman-La Roche AG Basel: Salary
Actelion, ADAMAS, Bayer Healthcare, Genzyme, Novartis, Acorda, Roche, AbbVie, Synthon, Avanir, Questcor, Osmotica, Biogen Idec, and Teva:
Consulting agreements, speaker honoraria, and grant/research financial support
Acorda Therapeutics, Avanir, Bayer HealthCare Pharmaceuticals, Novartis, Osmotica, Roche/Genentech, Sanofi Genzyme and Teva Neuroscience.: consulting fees and/or research support from and/or served on speakers’ bureaux
Acorda Therapeutics, Avanir, Bayer HealthCare Pharmaceuticals, Novartis, Osmotica, Roche/Genentech, Sanofi Genzyme and Teva Neuroscience.: consulting fees and/or research support from and/or served on speakers’ bureaux
I
Biogen Idec:
Consulting Fee
Genzyme/Sanofi: Contracted research
Genzyme/Sanofi: Consulting Fee
Bioge. Genentech, Genzyme/Sanofi: Contracted research
Genzyme/Sanofi: Contracted research
Genzyme/Sanofi: Consulting Fee
Bioge. Genentech, Genzyme/Sanofi: Contracted research
Almirall, bayer, Biogen, Merck Serono, Novartis, Roche, Sanofi, and Teva:
Speaking and advisory fees
Almirall, Biogen, Merck Serono, Novartis, Roche, Sanofi, and Teva: Speaking and advisory fees
Almirall, Biogen, Merck Serono, Novartis, Roche, Sanofi, and Teva: Speaking and advisory fees
J
Teva UK:
Consulting Fee
Sanofi Genzyme: Consulting Fee
Merck: travel bursary
Sanofi Genzyme: Consulting Fee
Merck: travel bursary
Biogen:
Consulting Fee
and
Salary Support for Site Participation in Clinical Trial
Sanofi: Consulting Fee
Genzyme: Consulting Fee
Sanofi: Consulting Fee
Genzyme: Consulting Fee
Biogen:
Salary
Genentech, Inc.:
Salary
F. Hoffmann La-Roche Ltd.: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Roche: Salary
F. Hoffmann La-Roche Ltd.: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Roche: Salary
Sanofi:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Employee of Sanofi: Salary
Employee of Sanofi: Salary
K
AbbVie, Actelion, Biogen, Celgene, EMD Serono, Mylan, Novartis and Sanofi Genzyme.:
Consulting Fee
AbbVie, Actelion, Biogen, Celegene, EMD Serono, Mylan, Novartis and Sanofi Genzyme.:
Consulting Fee
Actelion: Contracted research
Actelion: Contracted research
Actelion, Sanofi:
Research grants
AbbVie, Actelion, Bayer, Biogen, Celgene, EMD Serono, Genentech, Mylan, Novartis, and Sanofi: Consulting Fee and Fees for non-CME services received directly from a commercial interest or its agent
AbbVie, Actelion, Bayer, Biogen, Celgene, EMD Serono, Genentech, Mylan, Novartis, and Sanofi: Consulting Fee and Fees for non-CME services received directly from a commercial interest or its agent
Actelion, Addex, Bayer, Biogen, Biotica, Genzyme, Lilly, Merck, Mitsubishi, Novartis, Ono Pharma, Pfizer, Receptos, Sanofi, Santhera, Siemens, Teva, UCB, and Xenoport:
Consulting Fee and Steering Committee, Advisory Board
Bayer, Biogen, Merck, Novartis, Sanofi, and Teva: Speaker fees
Bayer, Biogen, CSL Behring, Genzyme, Merck, Novartis, Sanofi, and Teva: Support of educational activities
Neurostatus: License fees
Bayer, Biogen, European Union, Merck, Novartis, Roche, Swiss MS Society, and Swiss National Research Foundation: Grants
Bayer, Biogen, Merck, Novartis, Sanofi, and Teva: Speaker fees
Bayer, Biogen, CSL Behring, Genzyme, Merck, Novartis, Sanofi, and Teva: Support of educational activities
Neurostatus: License fees
Bayer, Biogen, European Union, Merck, Novartis, Roche, Swiss MS Society, and Swiss National Research Foundation: Grants
Actelion, Addex, Bayer, Biogen, Biotica, Genzyme, Lilly, Merck, Mitsubishi, Novartis, Ono Pharma, Pfizer, Receptos, Sanofi, Santhera, Siemens, Teva, UCB, and Xenoport:
Consulting Fee
and
Steering Committee, Advisory Board
Bayer, Biogen, Merck, Novartis, Sanofi, and Teva: Speaker fees
Bayer, Biogen, CSL Behring, Genzyme, Merck, Novartis, Sanofi, and Teva: Support of educational activities
Neurostatus: License fees
Bayer, Biogen, European Union, Merck, Novartis, Roche, Swiss MS Society, and Swiss National Research Foundation: Grants
Actelion, Addex, Bayer, Biogen, Biotica, Genzyme, Lilly, Merck, Mitsubishi, Novartis, Ono Pharma, Pfizer, Receptos, Sanofi, Santhera, Siemens, Teva, UCB, and Xenoport: Consulting Fee and Steering Committee, Advisory Board
Bayer, Biogen, Merck, Novartis, Sanofi, and Teva: Speaker fees
Bayer, Biogen, CSL Behring, Genzyme, Merck, Novartis, Sanofi, and Teva: Support of educational activities
Neurostatus: License fees
Actelion, Addex, Bayer, Biogen, Biotica, Genzyme, Lilly, Merck, Mitsubishi, Novartis, Ono Pharma, Pfizer, Receptos, Sanofi, Santhera, Siemens, Teva, UCB, and Xenoport: Consulting Fee and Steering Committee, Advisory Board
Bayer, Biogen, Merck, Novartis, Sanofi, and Teva: Speaker fees
Bayer, Biogen, CSL Behring, Genzyme, Merck, Novartis, Sanofi, and Teva: Support of educational activities
Neurostatus: License fees
Bayer, Biogen, European Union, Merck, Novartis, Roche, Swiss MS Society, and Swiss National Research Foundation: Grants
Actelion, Addex, Bayer, Biogen, Biotica, Genzyme, Lilly, Merck, Mitsubishi, Novartis, Ono Pharma, Pfizer, Receptos, Sanofi, Santhera, Siemens, Teva, UCB, and Xenoport: Consulting Fee and Steering Committee, Advisory Board
Bayer, Biogen, Merck, Novartis, Sanofi, and Teva: Speaker fees
Bayer, Biogen, CSL Behring, Genzyme, Merck, Novartis, Sanofi, and Teva: Support of educational activities
Neurostatus: License fees
Actelion, Addex, Bayer, Biogen, Biotica, Genzyme, Lilly, Merck, Mitsubishi, Novartis, Ono Pharma, Pfizer, Receptos, Sanofi, Santhera, Siemens, Teva, UCB, and Xenoport: Consulting Fee and Steering Committee, Advisory Board
Accorda Therapeutics:
Speakers Bureau
Employee of and own stock and/or stock options in Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Biogen:
Consulting Fee
EMD Serono: Consulting Fee
Novartis: Consulting Fee
Roche: Consulting Fee
Sanofi: Consulting Fee
EMD Serono: Consulting Fee
Novartis: Consulting Fee
Roche: Consulting Fee
Sanofi: Consulting Fee
Hoffmann-La Roche Limited, EMD Serono, Sanofi Genzyme, Novartis Pharmaceuticals Canada Inc.:
Consulting Fee
Genzyme:
Contracted research
CMSC and NMSS:
Fellowship Funding
MS Journal-Experimental, Translational and Clinical and Journal of Clinical Neurology:
Co-editor/associated editor
MedImmune: Steering Committee Member
Ministry of Science & ICT, Sanofi, Teva-Handok, and UCB: Research support
Bayer Schering Pharma, Biogen, Eisai, HanAll BioPharma, MedImmune, Merck Serono, Novartis, Sanofi, Teva-Handok, and UCB: Speaking and/or consulting
MedImmune: Steering Committee Member
Ministry of Science & ICT, Sanofi, Teva-Handok, and UCB: Research support
Bayer Schering Pharma, Biogen, Eisai, HanAll BioPharma, MedImmune, Merck Serono, Novartis, Sanofi, Teva-Handok, and UCB: Speaking and/or consulting
Has served on advisory boards of Biogen, Genentech.:
Advisory Board
Biogen, Genentech:
Consulting Fee
Guthy-Jackson Charitable Foundation, National Multiple Sclerosis Society, Biogen Idec, Serono, Genzyme, Novartis.: Contracted research
Guthy-Jackson Charitable Foundation, National Multiple Sclerosis Society, Biogen Idec, Serono, Genzyme, Novartis.: Contracted research
Teva:
Consulting Fee
Biogen: Consulting Fee
Biogen: Consulting Fee
F. Hoffmann-La Roche Ltd:
Employee of
and
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Acorda and Genzyme:
Consulting Fee
Roche and MS Society of Canada: Contracted research
Roche and MS Society of Canada: Contracted research
Novartis Pharmaceuticals Corporation:
Salary
Employee of Biogen:
Salary
Biogen and EMD Serono, Inc.:
Consulting Fee
Biogen, EMD Serono, Inc., Genzyme, Mallinckrodt, Novartis, and Teva: Honoraria and Speakers Bureau
Biogen, Genentech, Genzyme, Mallinckrodt, and Novartis: Contracted research
Biogen, EMD Serono, Inc., Genzyme, Mallinckrodt, Novartis, and Teva: Honoraria and Speakers Bureau
Biogen, Genentech, Genzyme, Mallinckrodt, and Novartis: Contracted research
Avanir, Biogen Idec, Celgene Corporation, Department of Defense, ER Squibb & Sons, Genentech, Johnson & Johnson, Lourie Foundation, Multicell, Osmotica, National Institutes of Health, National Multiple Sclerosis Society, Novartis Pharmaceuticals:
Consulting Fee
and
Contracted research
Slomo and Cindy Silvian Foundation, Teva Neurosciences and the Multiple Sclerosis Foundation: Consulting Fee and Contracted research
Slomo and Cindy Silvian Foundation, Teva Neurosciences and the Multiple Sclerosis Foundation: Consulting Fee and Contracted research
Actelion, Biogen, Merck Serono, Novartis, Celgene, Roche, Sanofi, and Teva and supported by Ministry of Education of Czech Republic (PROGRES Q27/LF1):
Honoraria and grant support
L
Acorda Therapeutics, Bayer, Biogen, Cephalon, EMD Serono, Novartis, Pfizer, Questcor, Sanofi, Strativa, Teva, and UCB:
Consulting Fee
Bayer, Novartis, Biogen Idec:
Speakers Bureau
Merck Serono, Novartis, Bayer: Consulting Fee
Bayer: Fees for non-CME services received directly from a commercial interest or its agent
Merck Serono, Novartis, Bayer: Consulting Fee
Bayer: Fees for non-CME services received directly from a commercial interest or its agent
Bayer Pharaceuticals:
Salary
Novartis:
Speakers Bureau
Genzyme, Novartis, Teva and Acorda Therapeutics:
Served on advisory board and speakers bureau
Employee of and holds stock and/or stock options in Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
L. Leocani received honoraria for consulting services or speaking activities from Roche, Novartis, Merck KGaA, Biogen, and Almirall:
Consulting Fee
Genentech/Roche:
Salary
NIH/NINDS:
Contracted research
F. Hoffmann-La Roche Ltd:
Employee of
Canadian Institute of Health Research and MS Society of Canada; is Emeritus Director of the UBC MS/MRI Research Group which was contracted to perform central analysis of MRI scans for therapeutic trials with Novartis, Perceptives, Roche and Sanofi-Aventis:
Contracted research
Investigator-initiated independent studies from Genzyme, Merck-Serono, Novartis and Roche: Grant support
Vertex Pharmaceuticals: Consultant
Opexa Therapeutics: Served on Data and Safety Advisory Board
Adelphi Group, Celgene, Novartis and Roche: Served on Scientific Advisory Board
Supported by non-restricted education grants from Teva, Novartis and Biogen: Given lectures
Investigator-initiated independent studies from Genzyme, Merck-Serono, Novartis and Roche: Grant support
Vertex Pharmaceuticals: Consultant
Opexa Therapeutics: Served on Data and Safety Advisory Board
Adelphi Group, Celgene, Novartis and Roche: Served on Scientific Advisory Board
Supported by non-restricted education grants from Teva, Novartis and Biogen: Given lectures
Bayer, Biogen, Merck Serono, Novartis, Roche, Sanofi, and Teva, with approval by the HR-Department, Cologne General Hospital, and University of Cologne:
Honoraria for consulting and speaking at symposia
Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
AbbVie, Acorda, Actelion, Akros, Amgen, Bayer HealthCare Pharmaceuticals, Biogen Idec, EMD Serono, Forward Pharma, MedDay, MedImmune, Novartis, Osmotica, Questcor Mallinckrodt, Receptos, Roche Genentech, Sanofi Genzyme, Teva Neuroscience, TG Therapeutics,:
Consulting Fee
and
Contracted research
Toyama: Advisory Board, DSMB and Consulting Fee
Regeneron: Advisory Board, DSMB and Consulting Fee
Abbvie: Advisory Board, DSMB and Consulting Fee
TG Therapeutics: Advisory Board, DSMB and Consulting Fee
Akros: Advisory Board, DSMB and Consulting Fee
Forward Pharma: Advisory Board, DSMB and Consulting Fee
Receptos/Celgene: Advisory Board, DSMB and Consulting Fee
MedImmune: Advisory Board, DSMB and Consulting Fee
Roche/Genentech: Advisory Board, DSMB and Consulting Fee
Accorda: Advisory Board, DSMB and Consulting Fee
Sanofi/Genzyme: Advisory Board, DSMB and Consulting Fee
Actelion: Advisory Board, DSMB and Consulting Fee
EMD Serono: Advisory Board, DSMB and Consulting Fee
Bayer Healthcare Pharmaceuticals: Advisory Board, DSMB and Consulting Fee
NMSS: Contracted research
NIH: Contracted research
Transparency Life Sciences: Contracted research
Celgene: Contracted research
Sanofi: Contracted research
Genzyme: Contracted research and Speakers Bureau
Teva Neuroscience: Advisory Board, DSMB , Consulting Fee and Contracted research
Novartis Pharmaceuticals Corp: Advisory Board, DSMB , Consulting Fee and Contracted research
Biogen Idec: Advisory Board, DSMB , Consulting Fee and Contracted research
Medday: Advisory Board, DSMB and Consulting Fee
Atara Biotherapeutics: Advisory Board, DSMB and Consulting Fee
Polpharma: Advisory Board, DSMB and Consulting Fee
Mapi Pharma: Advisory Board, DSMB and Consulting Fee
Innate Immunotherapeutics: Advisory Board, DSMB and Consulting Fee
Apitope: Advisory Board, DSMB and Consulting Fee
Genentech (non-promotional): Speakers Bureau
Genzyme (non-promotional): Speakers Bureau
Multiple Sclerosis and Related Disorders: co-chief editor, Multiple Sclerosis and Related Disorders
Toyama: Advisory Board, DSMB and Consulting Fee
Regeneron: Advisory Board, DSMB and Consulting Fee
Abbvie: Advisory Board, DSMB and Consulting Fee
TG Therapeutics: Advisory Board, DSMB and Consulting Fee
Akros: Advisory Board, DSMB and Consulting Fee
Forward Pharma: Advisory Board, DSMB and Consulting Fee
Receptos/Celgene: Advisory Board, DSMB and Consulting Fee
MedImmune: Advisory Board, DSMB and Consulting Fee
Roche/Genentech: Advisory Board, DSMB and Consulting Fee
Accorda: Advisory Board, DSMB and Consulting Fee
Sanofi/Genzyme: Advisory Board, DSMB and Consulting Fee
Actelion: Advisory Board, DSMB and Consulting Fee
EMD Serono: Advisory Board, DSMB and Consulting Fee
Bayer Healthcare Pharmaceuticals: Advisory Board, DSMB and Consulting Fee
NMSS: Contracted research
NIH: Contracted research
Transparency Life Sciences: Contracted research
Celgene: Contracted research
Sanofi: Contracted research
Genzyme: Contracted research and Speakers Bureau
Teva Neuroscience: Advisory Board, DSMB , Consulting Fee and Contracted research
Novartis Pharmaceuticals Corp: Advisory Board, DSMB , Consulting Fee and Contracted research
Biogen Idec: Advisory Board, DSMB , Consulting Fee and Contracted research
Medday: Advisory Board, DSMB and Consulting Fee
Atara Biotherapeutics: Advisory Board, DSMB and Consulting Fee
Polpharma: Advisory Board, DSMB and Consulting Fee
Mapi Pharma: Advisory Board, DSMB and Consulting Fee
Innate Immunotherapeutics: Advisory Board, DSMB and Consulting Fee
Apitope: Advisory Board, DSMB and Consulting Fee
Genentech (non-promotional): Speakers Bureau
Genzyme (non-promotional): Speakers Bureau
Multiple Sclerosis and Related Disorders: co-chief editor, Multiple Sclerosis and Related Disorders
Almirall, Biogen, Novartis, Sanofi, and Teva:
Scientific advisory boards
Biogen, Novartis, Sanofi, and Teva: Travel support and/or lecture honoraria
Acta Neurologica Scandinavica: Editorial board
Biogen, Novartis, and Teva: Unconditional research support
Biogen, Novartis, Sanofi, and Teva: Travel support and/or lecture honoraria
Acta Neurologica Scandinavica: Editorial board
Biogen, Novartis, and Teva: Unconditional research support
Dr. Lynch has participated in multi-center clinical trials in MS funded by Biogen, Genzyme, Teva, Sanofi, Novartis, Opexa, Roche, NIH, NMSS, Acorda, Sun Pharma, Vaccinex, and Actelion,:
clinical trials research
Sanofi:
Employee
M
Biogen, Merck, Novartis, Sanofi, and Teva:
Research support
Bayer, Biogen, Merck, Novartis, Roche, Sanofi, and Teva: Compensation for advisory board and/or speaking fees
Bayer, Biogen, Merck, Novartis, Roche, Sanofi, and Teva: Compensation for advisory board and/or speaking fees
Abbott:
Consulting Fee
Enspire: Receipt of Intellectual Property Rights / Patent Holder
Enspire: Receipt of Intellectual Property Rights / Patent Holder
Genentech, Inc.:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Employee of and holds stock and/or stock options in Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Sanofi:
Employee
F. Hoffmann-La Roche Ltd:
Employee of
F. Hoffmann-La Roche: Salary
F. Hoffmann-La Roche: Salary
F. Hoffmann-La Roche Ltd:
Employee of
and
Salary
... organizations including pharmaceutical companies.:
Contracted research
A. V. Margulis works for RTI Health Solutions, a business unit of RTI International, which has been compensated for this research. RTI International is an independent, nonprofit research organization that conducts work for government, public, and private: Contracted research
A. V. Margulis works for RTI Health Solutions, a business unit of RTI International, which has been compensated for this research. RTI International is an independent, nonprofit research organization that conducts work for government, public, and private: Contracted research
Genentech/Roche, Biogen, Teva, EMD Serono, Bayer, Novartis, Genzyme/Sanofi, and Cellgene:
Consulting Fee
Genentech Inc., A Member of the Roche Group:
Receipt of Intellectual Property Rights / Patent Holder
F. Hoffmann-La Roche Ltd: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Genentech Inc: Salary
F. Hoffmann-La Roche Ltd: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Genentech Inc: Salary
Bayer-Schering, Biogen, Merck-Serono, Novartis, Roche, Sanofi, and Teva:
Research and travel grants, honoraria for MS expert advice and speaker’s fees
Sanofi Genzyme:
Consulting Fee
and
Honoraria
Novartis: Consulting Fee and Honoraria
Genentech: Consulting Fee and Honoraria
Biogen: Consulting Fee and Honoraria
Novartis: Consulting Fee and Honoraria
Genentech: Consulting Fee and Honoraria
Biogen: Consulting Fee and Honoraria
Biogen, EMD Serono, Genentech, Novartis, Sanofi, and Teva:
Consulting Fee
and
Fees for non-CME services received directly from a commercial interest or its agent
Roche Products Ltd:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Roche Products Ltd: Salary
Roche Products Ltd: Salary
NIH:
Grant Number TL1 TR001078 FROM NCATS AND NIH Roadmap for Medical Research
Celgene:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Fibrogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Fibrogen: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Sanofi:
Employee
Novartis Pharmaceuticals Corporation:
Salary
Novartis:
Salary
Personal compensation from Biogen for advisory board activities:
Advisory Board
Spouse holds stock in Biogenspouse holds stock in Biogen and is employed by Sanofi: Spouse disclosures
Spouse holds stock in Biogenspouse holds stock in Biogen and is employed by Sanofi: Spouse disclosures
teva UK:
teaching fee
Merck: Consulting Fee
Merck: Consulting Fee
Accordant Health Services, Acorda Therapeutics, Alkermes, Biogen Idec, EMD Serono, Genentech/Roche, Genzyme, GSK, Mallinckrodt Pharmaceuticals [Questcor], Novartis, Roche, Teva:
Consulting Fee
Biogen Idec, Genentech, Novartis, Questcor, Roche, Sanofi: Fees for non-CME services received directly from a commercial interest or its agent
Biogen Idec, Genentech, Novartis, Questcor, Roche, Sanofi: Fees for non-CME services received directly from a commercial interest or its agent
Sanofi:
Employee
Hoffmann-La Roche Ltd:
Consulting Fee
National Multiple Sclerosis Society: Contracted research
National Multiple Sclerosis Society: Contracted research
Bayer:
MSNA (Award prize)
Celgene:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Genentech:
Consulting Fee
and
Grant Funding
Sanofi:
Employee
Genentech:
Consulting Fee
Teva: Speakers Bureau
Genzyme: Speakers Bureau
Teva: Speakers Bureau
Genzyme: Speakers Bureau
Roche:
Salary
TG Therapeutics:
employee
Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Employee of Biogen: Salary
Employee of Biogen: Salary
Almirall, Bayer, Biogen, Genzyme, Merck, Novartis, Oryzon,Receptos, Roche, Sanofi-Genzyme, Teva:
Consulting Fee
Almirall, Bayer, Biogen, Genzyme, Merck, Novartis, Oryzon,Receptos, Roche, Sanofi-Genzyme, Teva:
Consulting Fee
Almirall, Bayer Schering Pharma, Biogen, Genentech, Genzyme, GSK, Merck Serono, MS International Federation, National Multiple Sclerosis Society, Novartis, Roche, Sanofi-Aventis, and Teva:
Speaking honoraria and travel expenses for scientific meetings or has participated in steering committees or in advisory boards for clinical trials
MSJ: Editor for clinical cases
MSJ: Editor for clinical cases
Celgene:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
biogen, celgene, genzyme:
Consulting Fee
and
Speakers Bureau
Biogen Idec, EMD Serono, Genzyme, Novartis, and Roche:
Advisory Board
,
Consulting Fee
and
Speakers Bureau
Novartis, Genzyme and Roche: site principal investigator for clinical trials
Genzyme: investigator initiated trial funding
Novartis, Genzyme and Roche: site principal investigator for clinical trials
Genzyme: investigator initiated trial funding
Biogen, Genzyme- investigator-initiated studies Site PI of studies sponsored by Biogen, Sun Pharma Teva provides free med for a clinical trial of which I am PI Royalties from UpToDate for editorial duties:
Contracted research
and
Royalty
MyHealios:
Consulting Fee
Sanofi:
Employee
Acorda Therapeutics, Inc:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
N
Alkermes, Biogen, EMD Serono, Genzyme, Novartis, Teva:
Consulting Fee
Acorda, Genentech: Speakers Bureau
Acorda, Genentech: Speakers Bureau
Biogen and Sanofi:
Speaking fees and research support
Biogen: Royalty fees for licenses
Biogen: Royalty fees for licenses
Biogen, Genentech, Sanofi-Genzyme, Acorda Therapeutics, Avanir, EMD Serono, Novartis, Teva Neuroscience:
Consulting Fee
and
Speakers Bureau
F. Hoffmann-La Roche Ltd:
Employee of
Questcor Pharmaceuticals:
Consulting Fee
Teva Neuroscience: Consulting Fee
Biogen: Consulting Fee
Pfizer: Consulting Fee
Accorda: Consulting Fee
Serono: Consulting Fee
Novartis: Consulting Fee
Genzyme Pharmaceuticals: Consulting Fee
Teva Neuroscience: Consulting Fee
Biogen: Consulting Fee
Pfizer: Consulting Fee
Accorda: Consulting Fee
Serono: Consulting Fee
Novartis: Consulting Fee
Genzyme Pharmaceuticals: Consulting Fee
Employee and stockholder of Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
CMSC grant:
CMSC Grant
Hoffmann-La Roche Limited, Teva Canada Innovation, EMD Serono, Sanofi Genzyme, Biogen Canada:
Consulting Fee
Biogen, Genentech, Novartis, Celgene, Serono, Syntimmune:
Consulting Fee
and
Contracted research
Biogen Idec:
Advisory committe
,
Consulting Fee
and
Speakers Bureau
Novartis: Advisory committe , Consulting Fee and Speakers Bureau
Sanofi Genzyme: Advisory committe , Consulting Fee and Speakers Bureau
Genentch: Advisory committe , Consulting Fee and Speakers Bureau
Novartis: Advisory committe , Consulting Fee and Speakers Bureau
Sanofi Genzyme: Advisory committe , Consulting Fee and Speakers Bureau
Genentch: Advisory committe , Consulting Fee and Speakers Bureau
O
Genzyme:
Consulting Fee
Merck: Consulting Fee
Genzyme: Contracted research
Novartis: Contracted research
Genentech: Contracted research
Merck: Consulting Fee
Genzyme: Contracted research
Novartis: Contracted research
Genentech: Contracted research
Celgene:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Alexion, Biogen, Merck Serono, Novartis, Roche, Sanofi, and Teva:
Speaker honoraria and compensation for consulting services
P
Teva UK:
teaching fee
Sanofi Genzyme: Consulting Fee
Merck: Consulting Fee
Sanofi Genzyme: Consulting Fee
Merck: Consulting Fee
Icometrix:
Board member
Biogen:
Salary
F. Paul serves on the scientific advisory board for Novartis; received speaker honoraria and travel funding from Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis/Genzyme, Merck Serono, Alexion, Chugai, MedImmune, and Shire; is an academic editor for PLo:
Consulting Fee
Biogen:
Research support
Novartis:
Salary
Biogen, Merck Serono, Novartis, Roche, and Sanofi:
Consulting and/or speaking fees and grant/research support
Biogen, Novartis, Oxford PharmaGenesis, Teva (multiple sclerosis):
Consulting Fee
Acorda, Biogen, Genzyme, and Teva:
Consulting Fee
Acorda Therapeutics:
Speakers Bureau
EMD Serono, Inc., Rockland, MA, USA (a business of Merck KGaA, Darmstadt, Germany):
Employment
Novartis Pharmaceuticals Corporation:
Salary
Ipsen:
Employment
National Multiple Sclerosis Society:
Funding
Employee of Sanofi:
Salary
Actelion, Biogen, Merck, Novartis, Sanofi, and Teva:
Consulting and/or speaking fees, research, and travel grants
Biogen, Genzyme, Roche, Merck-Serono, Novartis, Sanofi and Teva: Consulting Fee
Biogen, Genzyme, Roche, Merck-Serono, Novartis, Sanofi and Teva: Consulting Fee
Genentech, Inc.:
Salary
Roche and Genentech: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Roche and Genentech: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
managing partner of ITAM:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Novartis Pharmaceuticals Corporation:
Salary
R
Coherus:
Consulting Fee
Eisai: Consulting Fee
Cipla: Consulting Fee
Genentech: Contracted research
Actelion: Contracted research
Novartis: Contracted research
Immune Tolerance Network: Contracted research
Alkermes: Contracted research
Journal of Neuroimmunology: Honoraria as Editor in Chief
Eisai: Consulting Fee
Cipla: Consulting Fee
Genentech: Contracted research
Actelion: Contracted research
Novartis: Contracted research
Immune Tolerance Network: Contracted research
Alkermes: Contracted research
Journal of Neuroimmunology: Honoraria as Editor in Chief
Celgene:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Bayer HealthCare:
Employee of Bayer HealthCare
EMD Serono, Biogen Idec, Sanofi-Aventis, Genzyme, Novartis, Teva Neurosciences, Acorda, and Roche/Genentech:
received honoraria for lectures and steering committee meetings
Genentech: Consulting Fee and Grant Support & Honoraria
Genzyme: Consulting Fee and Honoraria
Novartis: Consulting Fee and Grant Support & Honoraria
EMD Serono: Consulting Fee and Honoraria
Biogen: Consulting Fee and Grant Support & Honoraria
Teva: Honoraria
Genentech: Consulting Fee and Grant Support & Honoraria
Genzyme: Consulting Fee and Honoraria
Novartis: Consulting Fee and Grant Support & Honoraria
EMD Serono: Consulting Fee and Honoraria
Biogen: Consulting Fee and Grant Support & Honoraria
Teva: Honoraria
Employee of and own stock and/or stock options in Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Biogen:
Consulting Fee
and
Speakers Bureau
Genzyme: Contracted research and Speakers Bureau
Teva: Speakers Bureau
Novartis: Speakers Bureau
NMSS: Contracted research
Genzyme: Contracted research and Speakers Bureau
Teva: Speakers Bureau
Novartis: Speakers Bureau
NMSS: Contracted research
Biogen, Genzyme, Teva, Genentech, and EMD Serono.:
Consulting Fee
Employee of and own stock and/or stock options in Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Merck, Biogen Idec, Bayer Schering Pharma, Boehringer-Ingelheim, Sanofi-Aventis, Genzyme, Novartis, Teva Pharmaceutical Industries, and Serono Symposia International Foundation:
Honoraria for lectures/steering committee meetings
Almirall, Apple Healthcare, Baxter, Bayer, Biogen Idec, Boehringer-Ingelheim, Cerner, Daiichi Sankyo, Genpharm, Genzyme, Medtronic, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Siemens AG and Teva:
Speakers Bureau
Bayer, EMD Serono, Novartis, Teva, MS Society of Canada, Canadian Institute of Health Research, Hertie Foundation, Oberfranken-Stiftung and German Neurology Foundation: Contracted research
Abbvie, Bayer, Biogen Idec, Novartis, Merck KGaA, Teva, German Multiple Sclerosis Society and Canada Drug Review: Consulting Fee
Bayer, EMD Serono, Novartis, Teva, MS Society of Canada, Canadian Institute of Health Research, Hertie Foundation, Oberfranken-Stiftung and German Neurology Foundation: Contracted research
Abbvie, Bayer, Biogen Idec, Novartis, Merck KGaA, Teva, German Multiple Sclerosis Society and Canada Drug Review: Consulting Fee
Novartis Pharmaceuticals Corporation:
Salary
... private organizations including pharmaceutical companies. RTI Health Solutions received contract funding from Roche, with retention of independent publication.:
Contracted research
Elena Rivero-Ferrer works for RTI Health Solutions, a business unit of RTI International, which has been compensated for this research. RTI International is an independent, nonprofit research organization that conducts work for government, public, and...: Contracted research
Elena Rivero-Ferrer works for RTI Health Solutions, a business unit of RTI International, which has been compensated for this research. RTI International is an independent, nonprofit research organization that conducts work for government, public, and...: Contracted research
Greenwich Biosciences and Insys Therapeutics:
Contracted research
and
non-cme education for LivaNova
Acorda Therapeutics, Inc:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Mecrk:
Consulting Fee
Roche: Consulting Fee
Sanofi Genzyme: Consulting Fee
Teva UK: Consulting Fee
Biogen: Consulting Fee
Roche: Consulting Fee
Sanofi Genzyme: Consulting Fee
Teva UK: Consulting Fee
Biogen: Consulting Fee
Acorda Therapeutics, Inc:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Biogen:
Recieved research support
Teva: Received research support
Guthy Jackson Charitable Foundation: Research Support
National MS Society: Research Support
Teva: Received research support
Guthy Jackson Charitable Foundation: Research Support
National MS Society: Research Support
Novartis:
Consulting Fee
and
Contracted research
Bayer, Biogen, Bracco, Novartis, Sanofi, and Stendhal:
Consulting and/or speaking fees
Teva Neuroscience:
Grant
Acorda Therapeutics, Inc:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
S
Received grant support and speaker honoraria from Biogen:
Contracted research
and
Speakers Bureau
Biogen, Genentech and Genzyme:
Consultant
Employee of and holds stock and/or stock options in Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Teva:
Consulting Fee
Biogen: Consulting Fee
Roche: Consulting Fee
Serono: Consulting Fee
Sanofi: Consulting Fee
Novartis: Consulting Fee
Biogen: Consulting Fee
Roche: Consulting Fee
Serono: Consulting Fee
Sanofi: Consulting Fee
Novartis: Consulting Fee
Biogen, Merck Serono, Novartis, Sanofi, and Teva:
Consulting and/or speaking fees and grant/research support
Novartis Pharmaceuticals Corporation:
Salary
Biogen:
Contracted research
Celgene:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Biogen, Bayer Schering, Genzyme, Merck, Teva, Sanofi and Roche:
travel grants and honoraria for lectures and consulting
Biogen, Genzyme, Merck, Novartis, Ono Pharma, Receptos, Roche, Synthon, and Teva:
Consulting Fee
Biogen, Merck, Novartis, Roche, Sanofi, and Synthon:
Consulting and/or speaking fees
teva UK:
Teaching fee
Sanofi:
Employee
Celgene:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Sanofi:
Employee
Owner of Sleep Health Education, LLC:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Novartis Pharmaceuticals Corporation:
Salary
Biogen:
Contracted research
Novartis: Contracted research
Novartis: Contracted research
Acorda, Alkermes, Biogen, MedImmune, Novartis, Roche, Sanofi:
Research support
Acorda, Bayer, Biogen, EMD Serono, Genentech, Pfizer, Novartis, Sanofi, and Teva: Speaking and/or consulting
Acorda, Bayer, Biogen, EMD Serono, Genentech, Pfizer, Novartis, Sanofi, and Teva: Speaking and/or consulting
Biogen, Celgene, Genentech, Sanofi Genzyme, Teva:
Consulting Fee
,
Contracted research
and
Speakers Bureau
The author’s employer (RTI Health Solutions) performs work for multiple pharma and biotech companies, including the study sponsor, on a contract basis; however the author does not receive any of those funds directly nor is his/her salary contingent upon t:
Contracted research
Sanofi:
Employee
Employee of Sanofi: Salary
Employee of Sanofi: Salary
GEOMC, Inc:
Travel expenses from the manufacturers of Scrambler Therapy machines, to teach at the 5th Annual Conference on Scrambler Therapy
Acorda, Biogen, Genentech, Genzyme, Novartis, and Teva:
Consulting Fee
Biogen and Genentech: Contracted research
Acorda, Biogen, Genentech, Genzyme, Novartis, and Teva: Speakers Bureau
Biogen and Genentech: Contracted research
Acorda, Biogen, Genentech, Genzyme, Novartis, and Teva: Speakers Bureau
Merck, Teva, GSK, and Novartis; has received speaker honoraria from Biogen Idec, Merck, Teva, Sanofi-Aventis, Genzyme, and Novartis:
steering committees or independent data monitoring boards in trials sponsored by
Biogen, Merck, Teva, Novartis, Roche, and Genzyme: Department received research support
Biogen, Merck, Novartis, Teva, MedDay Pharmaceuticals, and GSK: Advisory boards
Biogen, Merck, Teva, Novartis, Roche, and Genzyme: Department received research support
Biogen, Merck, Novartis, Teva, MedDay Pharmaceuticals, and GSK: Advisory boards
Actelion, Novartis, Sanofi Genzyme, Electrocore, Merck and TEVA.:
Consulting Fee
Abbvie, Atreca, Celgene/Receptos, Novartis, Teva, Tolerion, and EMD Serono:
Consulting Fee
Atara, Biogen, and Celgene: Contracted research
Atara, Biogen, and Celgene: Contracted research
Novartis:
Salary
F. Hoffmann-La Roche Ltd:
Employee of
and
Salary
TG Therapeutics:
employee
Ipsen:
Employment
Novartis:
Consulting Fee
and
Speakers Bureau
Sanofi Genzyme:
Consulting Fee
,
Contracted research
and
Speakers Bureau
T
Teva UK:
teaching fee
Novartis, Sanofi and UniQure:
Consulting Fee
and
Contracted research
Celgene:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Novartis Pharmaceuticals Corporation:
Salary
Biogen Idec, Teva Neurosciences, EMD Serono, Avanir, Genzyme and Novartis:
Contracted research
Sanofi:
Employee
Sanofi: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Employee of Sanofi: Salary
Sanofi: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Employee of Sanofi: Salary
Acorda Therapeutics, Genzyme and Teva Neuroscience:
Consulting Fee
Novartis Pharmaceuticals Corporation:
Salary
Biogen, Genzyme, and Novartis:
Consulting Fee
Biogen: Speakers Bureau
Biogen: Speakers Bureau
Biogen, Chugai, Roche, Sanofi, and Teva:
Consulting and/or speaking fees
Biogen, Chugai, Roche, Sanofi, and Teva: Grant/research support
Roche: Contracted research
Genzyme: Contracted research
Roche: Consulting Fee
Teva: Consulting Fee
Canada Innovation: Consulting Fee
Mercke/EMD: Consulting Fee
EMD: Consulting Fee
Sanofi: Consulting Fee
Sanofi Genzyme, Teva Neuroscience: Speakers Bureau
Sanofi Genzyme, Roche, Chugai, Novartis, Biogen: Contracted research
Sanofi Genzyme, Roche, Teva Neuroscience, Novartis, Biogen, EMD Serono: Consulting Fee
Biogen, Roche, EMD Serono and Teva Pharmaceuticals: Consulting Fee
Biogen, Chugai, CIHR, Roche, Michael Smith Foundation and the MS Society of Canada: Contracted research
Biogen, Chugai, Roche, Sanofi, and Teva: Grant/research support
Roche: Contracted research
Genzyme: Contracted research
Roche: Consulting Fee
Teva: Consulting Fee
Canada Innovation: Consulting Fee
Mercke/EMD: Consulting Fee
EMD: Consulting Fee
Sanofi: Consulting Fee
Sanofi Genzyme, Teva Neuroscience: Speakers Bureau
Sanofi Genzyme, Roche, Chugai, Novartis, Biogen: Contracted research
Sanofi Genzyme, Roche, Teva Neuroscience, Novartis, Biogen, EMD Serono: Consulting Fee
Biogen, Roche, EMD Serono and Teva Pharmaceuticals: Consulting Fee
Biogen, Chugai, CIHR, Roche, Michael Smith Foundation and the MS Society of Canada: Contracted research
Sanofi:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Employee of Sanofi: Salary
Employee of Sanofi: Salary
V
CEO of Icometrix:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Biogen, Bayer Schering, Genzyme, Merck, Teva, Sanofi and Roche:
travel grants
Biogen, Bayer Schering, Sanofi, Merck, Roche, Teva and Novartis Pharma: Consulting Fee
Novartis Pharma, Bayer Schering, Sanofi and Roche: Contracted research
Biogen, Bayer Schering, Sanofi, Merck, Roche, Teva and Novartis Pharma: Consulting Fee
Novartis Pharma, Bayer Schering, Sanofi and Roche: Contracted research
Bayer-Schering, Biogen, Merck-Serono, Novartis, Roche, Sanofi, and Teva:
Research and travel grants, honoraria for MS expert advice and speaker’s fees
Merck KGaA:
Salary
Almirall, Bayer, Biogen, Celgene, Merck Serono, Novartis, Sanofi, Servier, and Teva:
Consulting fees and/or speaking fees, and research support
Sanofi Genzyme:
Consulting Fee
Teva UK: Consulting Fee
Roche: Consulting Fee
Merck: Consulting Fee
Biogen: Consulting Fee
Teva UK: Consulting Fee
Roche: Consulting Fee
Merck: Consulting Fee
Biogen: Consulting Fee
Dr. Pablo Villoslada hold stocks in Bionure Inc, Spire Bioventures, Mint-Labs and Health Engineering and is an employee of Genentech Inc at present.:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Employee of Genentech:
Salary
Roche: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Roche: Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Novartis:
Contracted research
Hoffmann-La Roche Limited, Teva Canada Innovation, EMD Serono, Sanofi Genzyme, Biogen Canada, Novartis Pharmaceuticals Canada Inc.:
Consulting Fee
and
Unrestricted educational grant from EMD Serono, Hoffmann-La Roche Limited
Bayer-Schering, Biogen Idec, F. Hoffmann-La Roche Ltd, Genzyme, Novartis, Merck Serono, Sanofi Aventis and Teva Pharma:
Consulting Fee
and
Lecture fees, Travel Grants, Researc Support
W
Employee and stockholder of Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Sanofi, EMD Serono and Biogen:
Participation in advisory boards
F. Hoffmann-La Roche Ltd:
Employee of
and
Salary
National Institutes of Health, National Multiple Sclerosis Society, Novartis, Race to Erase MS and Roche:
Consulting Fee
and
Contracted research
Biogen Idec, Teva Neuroscience, EMD Serono, Novartis, Questcor, Sanofi Genzyme, Aspreva,:
Consulting Fee
,
Contracted research
and
Speakers Bureau
TG Therapeutics:
Employee
Huber-Verlag:
License fee payments
Neotope Bioscience, Novartis, and PML Consortium: Grant/research support
Bayer, Biogen, Behring, EMD Serono, Fresnius Medical Care, Merck Serono, Novartis, Sanofi, Roche, and Teva: Consulting and/or speaking fees
Bayer, Biogen, Behring, EMD Serono, Fresenius Medical Care, Merck Serono, Novartis, Sanofi, Roche, and Tevae: Consulting and/or speaking fees
Neotope Bioscience, Novartis, and PML Consortium: Grant/research support
Bayer, Biogen, Behring, EMD Serono, Fresnius Medical Care, Merck Serono, Novartis, Sanofi, Roche, and Teva: Consulting and/or speaking fees
Bayer, Biogen, Behring, EMD Serono, Fresenius Medical Care, Merck Serono, Novartis, Sanofi, Roche, and Tevae: Consulting and/or speaking fees
Roche, Sanofi-Genzyme, Merck, Novartis, Biogen:
Consulting Fee
Novartis, Roche: Contracted research
Teva, Roche, Sanofi-Genzyme, Merck, Novartis, Biogen: travel grants
Novartis, Roche: Contracted research
Teva, Roche, Sanofi-Genzyme, Merck, Novartis, Biogen: travel grants
Biogen Idec:
Consulting Fee
and
Speakers Bureau
Novartis: Consulting Fee , Contracted research and Speakers Bureau
Teva Neuroscience: Consulting Fee and Speakers Bureau
Mallingckrodt: Consulting Fee and Speakers Bureau
Sanofi Genzyme: Consulting Fee and Speakers Bureau
Genentech: Consulting Fee and Speakers Bureau
Novartis: Consulting Fee , Contracted research and Speakers Bureau
Teva Neuroscience: Consulting Fee and Speakers Bureau
Mallingckrodt: Consulting Fee and Speakers Bureau
Sanofi Genzyme: Consulting Fee and Speakers Bureau
Genentech: Consulting Fee and Speakers Bureau
Teva Neuroscience, Inc.:
Consulting Fee
Novartis Pharmaceuticals Corporation: Consulting Fee
Merck & Co., Inc.: Consulting Fee
Biogen Inc.: Consulting Fee
EMD Serono Inc.: Consulting Fee
Celgene Corporation: Consulting Fee
Sanofi S.A.: Consulting Fee
Alexion Pharmaceuticals Inc.: Contracted research
Novartis Pharmaceuticals Corporation: Consulting Fee
Merck & Co., Inc.: Consulting Fee
Biogen Inc.: Consulting Fee
EMD Serono Inc.: Consulting Fee
Celgene Corporation: Consulting Fee
Sanofi S.A.: Consulting Fee
Alexion Pharmaceuticals Inc.: Contracted research
Pfizer, BMS:
Contracted research
Pfizer, BMS, Roche, UCB, Lilly, Abbvie: Consulting Fee
Pfizer, BMS, Roche, UCB, Lilly, Abbvie: Consulting Fee
AbbVie, Alkermes, Biogen, Clene Nanomedicine, Forward Pharma, MedDay, Novartis, Roche Genentech, Sanofi Genzyme:
Consulting Fee
received royalties for monoclonal antibodies out-licenced to Chemicon International through UTHealth: Royalty
Alkermes: Consulting Fee
Biogen: Consulting Fee
Bionest: Consulting Fee
Celgene: Consulting Fee
Clene Nanomedicine: Consulting Fee
EMD Serono: Consulting Fee
Forward Pharma A/S: Consulting Fee
MedDay Pharmaceuticals: Consulting Fee
Novartis Pharmaceuticals: Consulting Fee
Otsuka: Consulting Fee
PTC Therapeutics: Consulting Fee
Roche Genentech: Consulting Fee
Sanofi Genzyme: Consulting Fee
Strategic Consultants International: Consulting Fee
rec'd through UTHealth from Millipore Corporation: Royalty
AbbVie, Alkermes, Biogen, Bionest, Celgene, Clene Nanomedicine, EMD Serono, Forward Pharma, MedDay Pharmaceuticals, Novartis, Otsuka, PTC Therapeutics, Roche, Sanofi Genzyme: Consulting Fee
monoclonal antibodies out-licensed to Chemicon International through UTHealth: Royalty
For monoclonal antibodies out-licenced to Chemicon International through UTHealth: Royalty
received royalties for monoclonal antibodies out-licenced to Chemicon International through UTHealth: Royalty
Alkermes: Consulting Fee
Biogen: Consulting Fee
Bionest: Consulting Fee
Celgene: Consulting Fee
Clene Nanomedicine: Consulting Fee
EMD Serono: Consulting Fee
Forward Pharma A/S: Consulting Fee
MedDay Pharmaceuticals: Consulting Fee
Novartis Pharmaceuticals: Consulting Fee
Otsuka: Consulting Fee
PTC Therapeutics: Consulting Fee
Roche Genentech: Consulting Fee
Sanofi Genzyme: Consulting Fee
Strategic Consultants International: Consulting Fee
rec'd through UTHealth from Millipore Corporation: Royalty
AbbVie, Alkermes, Biogen, Bionest, Celgene, Clene Nanomedicine, EMD Serono, Forward Pharma, MedDay Pharmaceuticals, Novartis, Otsuka, PTC Therapeutics, Roche, Sanofi Genzyme: Consulting Fee
monoclonal antibodies out-licensed to Chemicon International through UTHealth: Royalty
For monoclonal antibodies out-licenced to Chemicon International through UTHealth: Royalty
for monoclonal antibodies out-licensed to Chemicon International through UTHealth:
Royalty
AbbVie, Alkermes, Biogen, Bionest, Celgene, Clene Nanomedicine, EMD Serono, Forward Pharma, MedDay Pharmaceuticals, Novartis, Otsuka, PTC Therapeutics, Roche, Sanofi Genzyme: Consulting Fee
AbbVie, Alkermes, Biogen, Bionest, Celgene, Clene Nanomedicine, EMD Serono, Forward Pharma, MedDay Pharmaceuticals, Novartis, Otsuka, PTC Therapeutics, Roche, Sanofi Genzyme: Consulting Fee
Biogen:
research support
F. Hoffmann-La Roche Ltd:
Employee of
,
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
F. Hoffmann-La Roche Ltd: Employee of and Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
F. Hoffmann-La Roche Ltd: Employee of and Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Alkermes, Bayer, Biogen, EMD Serono, Genentech/Roche, Novartis, Sanofi, and Teva:
Consultant, principal investigator, and/or speaker fees
Paid consultant, speaker, and/or contract researcher for Acorda, Bayer, Biogen, EMD Serono, Genzyme, Novartis, Questcor, Receptos, Genentech/Roche, and Teva: Consulting Fee , Contracted research and Speakers Bureau
Paid consultant, speaker, and/or contract researcher for Acorda, Bayer, Biogen, EMD Serono, Genzyme, Novartis, Questcor, Receptos, Genentech/Roche, and Teva: Consulting Fee , Contracted research and Speakers Bureau
Biogen, Alkermes:
Contracted research
Alkermes:
Contracted research
Y
Employee and stockholder of Biogen:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
and
Salary
Z
Biogen:
Consulting Fee
Acorda, Biogen, Genzyme and Teva:
Speaker fees
F. Hoffmann-La Roche Ltd:
Ownership interest (stocks, stock options, or any ownership interest excluding diversified mutual funds)
Genentech, Inc.: Salary
Genentech, Inc.: Salary
Personal compensation for speaker and advisory board activities from Biogen, Teva:
Speakers Bureau
Biogen: Research Support
Biogen: Research Support
Novartis Pharmaceuticals Corporation:
Salary
Biogen, Novartis, Sanofi, and Teva:
Grant/research support
Almirall, Bayer Biogen, Merck, Novartis, Roche, Sanofi, and Teva: Consulting and/or speaking fees
Almirall, Bayer Biogen, Merck, Novartis, Roche, Sanofi, and Teva: Consulting and/or speaking fees
Teva Pharmaceuticals, Biogen Idec, EMD Serono, Sanofi Genzyme, Claret Medial, IMS Health, Novartis:
Consulting Fee
and
Speakers Bureau
Teva Pharmaceuticals, Sanofi Genzyme, Novartis, Claret Medical, Intekrin-Coherus, IMS Health: Contracted research
Teva Pharmaceuticals, Sanofi Genzyme, Novartis, Claret Medical, Intekrin-Coherus, IMS Health: Contracted research